LncRNA-UCA1 increases cisplatin resistance during bladder cancer chemotherapy by increasing the expression of Wnt6 and thus represents a potential target to overcome bladder cancer chemoresistance [15]. The gene discussed is UCA1; the disease is urinary bladder carcinoma.